Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9157836 | Atherosclerosis | 2005 | 7 Pages |
Abstract
These findings demonstrate that CS treatment reduced agonist-induced human neutrophil ROS production independent of p47phox phosphorylation and translocation from the cytosol to the membrane. However, this inhibition could be attributed to a reduction in translocation of another cytosolic NADPH oxidase protein, p67phox. Although neutrophil-generated ROS have been implicated in the pathogenesis of atherosclerosis, this does not appear to be the mechanism by which CS induces vascular injury.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
John S. Dunn, Brian M. Freed, Daniel L. Gustafson, Kathleen A. Stringer,